Does Nad+ Improve Brain Function?

Does NAD+ Improve Brain Function?

NAD+ plays a fundamental role in how brain cells produce energy, repair DNA, and manage cellular stress. Research suggests that NAD+ levels decline with age, and this decline has been associated with increased vulnerability to neurodegeneration and cognitive impairment. Whether supplementing with NAD+ precursors can meaningfully reverse or slow these changes in humans is a question the science has not yet fully answered.

The biological case is credible. The clinical evidence in humans, however, is still early-stage. Understanding the difference matters before drawing conclusions about supplementation.

How NAD+ Affects the Brain

NAD+ and Brain Energy Production

Brain cells are among the most metabolically demanding in the body. Neurons rely almost entirely on mitochondria to generate the energy required for signalling, repair, and survival. NAD+ sits at the centre of this process — it is a critical coenzyme in the mitochondrial reactions that convert nutrients into cellular energy (ATP).

When NAD+ availability falls, mitochondrial efficiency can decline. In the brain, this may translate to reduced energy supply for neurons, slower cellular repair, and greater susceptibility to oxidative stress. Research in animal models consistently links NAD+ depletion with impaired cognitive performance and accelerated neuronal damage.

NAD+ and DNA Repair in the Brain

The brain accumulates oxidative DNA damage over time. NAD+ is required by PARP enzymes, which are a primary DNA repair mechanism in neurons. As NAD+ levels fall with age, the capacity for this repair may also decline — a process thought to contribute to the gradual neuronal loss seen in ageing and neurodegenerative conditions.

NAD+ and Sirtuins in Cognitive Ageing

NAD+ is also required for sirtuin activity. Sirtuins are a family of proteins involved in regulating inflammation, stress responses, and mitochondrial health throughout the body, including in the brain. Sirtuin 1 (SIRT1) in particular has been associated with synaptic plasticity and neuroprotection in preclinical research. Whether sirtuin activation through raised NAD+ translates into measurable cognitive benefits in humans remains uncertain. Learn more in our complete guide to longevity.

What the Evidence Actually Shows

Animal Studies: Strong Signal, but Not Proof in Humans

The most compelling evidence for NAD+ and brain function comes from animal research. Studies in aged mice have shown that restoring NAD+ levels — typically through NMN or NR supplementation — can improve mitochondrial function in the brain, reduce neuroinflammation, and partially restore cognitive performance on memory tasks. These findings are biologically meaningful and have helped drive interest in NAD+ precursors.

However, translating animal findings to human outcomes requires caution. Mice metabolise NAD+ differently, age on a compressed timescale, and respond to interventions in ways that do not always replicate in human trials.

Human Evidence: Early and Incomplete

Human clinical trials investigating NAD+ precursors and brain function are small in number and limited in scope. Most trials have focused on demonstrating that NMN or NR can raise blood NAD+ levels — which they reliably do — rather than measuring meaningful changes in cognition, memory, or neurological markers.

A small number of human studies have explored NAD+ precursors in the context of mild cognitive impairment or Parkinson’s disease, showing some signals of tolerability and possible metabolic benefit. However, these trials are not large enough or long enough to establish that raising NAD+ produces clinically significant cognitive improvement in humans.

Current evidence indicates that NAD+ is important for brain health mechanistically. It does not yet confirm that supplementing with NAD+ precursors meaningfully improves cognition in healthy adults or delays neurodegeneration. For a broader view of how NAD+ biology fits into healthy ageing, see our NAD+ for longevity hub.

Neuroplasticity and NAD+

There is preclinical interest in NAD+’s potential role in supporting neuroplasticity — the brain’s capacity to form and reorganise neural connections. SIRT1 activity, which depends on NAD+, has been linked in animal models to synapse formation and memory consolidation. Whether this pathway is meaningfully influenced by oral NAD+ supplementation in humans has not been established.

Practical Ways to Support NAD+ for Brain Health

Lifestyle Foundations Come First

Exercise is one of the most reliably documented ways to support NAD+ biology. Endurance-style physical activity activates AMPK, which in turn stimulates NAD+ production pathways — particularly through the salvage pathway. Regular exercise also supports mitochondrial biogenesis and reduces neuroinflammation, both directly relevant to brain health. For more detail, see our article on whether exercise increases NAD+.

Intermittent fasting and caloric restriction have similarly been shown to elevate NAD+ levels in preclinical models, likely by reducing NAD+ consumption via PARP and CD38 and by activating energy-sensing pathways. Adequate sleep is also important — sleep disruption impairs the brain’s glymphatic clearance system and is associated with broader metabolic dysfunction that may accelerate NAD+ decline.

Dietary precursors matter too. Niacin (vitamin B3), tryptophan, and nicotinamide riboside occur naturally in foods including fish, poultry, dairy, and certain grains. These contribute to NAD+ synthesis through established biosynthetic pathways.

NAD+ Precursor Supplements: NMN and NR

Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are orally available precursors that reliably raise blood NAD+ levels in human trials. The question of whether one is meaningfully superior for brain health has not been resolved — differences in bioavailability and tissue uptake remain an active area of research. For a focused comparison, see our article on whether NMN is better than NR.

If considering supplementation, the most reasonable approach is to treat NAD+ precursors as a potential optimisation layer on top of established lifestyle practices — not a replacement for them. Evidence for cognitive benefit from supplements alone, without lifestyle foundations in place, is not currently supported by human clinical data.

Risks, Limitations, and Long-Term Safety

Short-Term Safety Profile

NMN and NR are generally well-tolerated in human trials conducted to date. Mild gastrointestinal symptoms — such as nausea or discomfort — have been reported at higher doses by some participants, but serious adverse events have not been documented in short-term studies. Both compounds have acceptable short-term safety profiles based on available evidence.

Long-Term Safety Remains Uncertain

Most human trials have lasted weeks to a few months. Meaningful long-term safety data — covering years of continuous use — does not yet exist for either NMN or NR. This is an important limitation. Sustained elevation of NAD+ and its downstream effects on pathways such as sirtuin activity, PARP function, and cellular proliferation over extended periods have not been systematically evaluated in humans.

There is also theoretical interest — though not established concern — around whether chronically elevated NAD+ could influence cancer-related pathways in certain contexts, given NAD+’s role in cell survival and repair. This does not make supplementation inadvisable for healthy adults, but it does reinforce the value of caution, appropriate dosing, and medical guidance where relevant.

Raising NAD+ Is Not Automatically Better

Higher NAD+ is not universally beneficial in every context. NAD+ biology is tightly regulated, and the relationship between NAD+ levels and outcomes is not simply linear. What the evidence shows is that preventing pathological decline in NAD+ with age is likely beneficial — not that pushing NAD+ as high as possible produces proportionally better outcomes. Anyone approaching this area through a longevity or cognitive health lens should hold this distinction clearly.

References and Resources

Frequently Asked Questions

Conclusion

NAD+ plays a well-established role in the biological processes that keep brain cells functioning — energy production, DNA repair, stress signalling, and mitochondrial health. Age-related decline in NAD+ is a plausible contributor to the cognitive changes seen in later life, and the mechanistic case for supporting NAD+ levels is credible.

What the current evidence does not yet confirm is that raising NAD+ through supplementation produces meaningful, measurable cognitive improvements in healthy humans. Animal research is promising; human trials remain limited in size, duration, and outcome scope. Treating NAD+ precursors as part of a carefully considered approach — alongside exercise, sleep, and metabolic health — reflects a more accurate reading of the evidence than viewing supplements as a direct cognitive enhancer.

The science continues to develop. Staying calibrated about what is established versus what is still emerging is the most useful position for anyone interested in NAD+ and brain health.